Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.64 AUD -3.76% Market Closed
Market Cap: 153m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Orthocell Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Orthocell Ltd
Capital Expenditures Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Orthocell Ltd
ASX:OCC
Capital Expenditures
-AU$942k
CAGR 3-Years
-71%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Capital Expenditures
-$271k
CAGR 3-Years
45%
CAGR 5-Years
1%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Capital Expenditures
-$1.3B
CAGR 3-Years
9%
CAGR 5-Years
0%
CAGR 10-Years
-12%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Capital Expenditures
-AU$5.6m
CAGR 3-Years
-87%
CAGR 5-Years
-85%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Capital Expenditures
-AU$10.8m
CAGR 3-Years
-222%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Capital Expenditures
-AU$307k
CAGR 3-Years
20%
CAGR 5-Years
8%
CAGR 10-Years
-4%

See Also

What is Orthocell Ltd's Capital Expenditures?
Capital Expenditures
-942k AUD

Based on the financial report for Jun 30, 2024, Orthocell Ltd's Capital Expenditures amounts to -942k AUD.

What is Orthocell Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-21%

Over the last year, the Capital Expenditures growth was -49%. The average annual Capital Expenditures growth rates for Orthocell Ltd have been -71% over the past three years , -21% over the past five years .

Back to Top